Janux Therapeutics, Inc. JANX
17.63 USD +1.57 (+9.78%)
At closeNov 6, 2026, 4:20 PM EST
17.63 0.00 0.00%
After hours · Nov 6, 4:20 PM ET
16.14 Day range 17.80
12.18 52-week range 34.74
- YTD
- +27.75%
- 1 year
- -38.49%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 10.00M | 10.59M | 8.08M | 8.61M | 3.64M | |
| 10.00M | 10.59M | 8.08M | 8.61M | 3.64M | |
| -157.67M | -98.85M | -72.98M | -67.09M | -32.93M | |
| -113.63M | -68.99M | -58.29M | -63.06M | -32.67M | |
| -1.83 | -1.28 | -1.32 | -1.52 | -1.39 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 53.15M | 431.42M | 20.02M | 52.24M | 36.40M | |
| 1.00B | 1.06B | 380.41M | 364.01M | 379.82M | |
| 44.74M | 38.73M | 36.06M | 43.27M | 13.50M | |
| 22.14M | 23.02M | 24.54M | 25.30M | 194.00K | |
| 956.82M | 1.02B | 344.35M | 320.74M | 366.33M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -82.23M | -43.81M | -50.58M | -42.92M | -16.98M | |
| -300.98M | -258.02M | -41.19M | 58.27M | -340.96M | |
| 4.95M | 713.24M | 59.55M | 500.00K | 386.52M | |
| -1.04M | -359.00K | -1.85M | -6.45M | -1.48M | |
| -378.27M | 411.40M | -32.22M | 15.84M | 28.59M |